SR formulations - no MD study? [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2007-01-23 19:32 (6695 d 09:13 ago) – Posting: # 484
Views: 13,662

Dear hirenpharm!

❝ I did not get me right by misfortune.

❝ I meant to say that the AUC(0-last) failing and AUC(0-24)passing.


Hhm, that's bad luck...
One possible reason: your last sampling points are close to LOQ, combined with a relatively long sampling interval (e.g., 16, 24, 36 h). In such a case it happens quite often that in the same subject t(last) will be 24 h for one formulation, and 36 h for the other. Such a difference mainly influences the intra-subject variability--which I would expect to be higher for AUC(last) than for AUC(24). The point estimate should not be influenced as much (differences will mean out).
Unfortunatelly you have to follow your statistical protocol; regulators do not like any kind of 'data dredging' / 'cherry picking'. :cherry picking:

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,681 registered users;
62 visitors (0 registered, 62 guests [including 19 identified bots]).
Forum time: 05:45 CEST (Europe/Vienna)

There are many questions which fools can ask
that wise men cannot answer.    George Pólya

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5